SCHEMBL24046900

SCHEMBL24046900

C#Cc1cccc(-c2cc(Cl)cc3c(=O)cc(-c4ccc(O)cn4)oc23)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1B1 Q16678 9/20 0.41
▸ CYP1A1 P04798 8/20 0.41
▸ CYP1A2 P05177 5/20 0.41
▸ GABRP O00591 1/20 0.37
▸ GABRD O14764 1/20 0.37
▸ GABRA1 P14867 1/20 0.37
▸ GABRB1 P18505 1/20 0.37
▸ GABRG2 P18507 1/20 0.37
▸ GABRB3 P28472 1/20 0.37
▸ GABRA5 P31644 1/20 0.37
▸ GABRA3 P34903 1/20 0.37
▸ GABRA2 P47869 1/20 0.37
▸ GABRB2 P47870 1/20 0.37
▸ GABRA4 P48169 1/20 0.37
▸ GABRE P78334 1/20 0.37
▸ GABRA6 Q16445 1/20 0.37
▸ GABRG1 Q8N1C3 1/20 0.37
▸ GABRG3 Q99928 1/20 0.37
▸ GABRQ Q9UN88 1/20 0.37
▸ CCNT1 O60563 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24046905 0.88 CYP1A1 (0.44) CYP1B1CYP1A1CYP1A2GABRPGABRD
SCHEMBL24046901 0.86 CSNK2A2 (0.45) CYP1B1CYP1A1CYP1A2GABRPGABRD
SCHEMBL24046746 0.79 CYP1A1 (0.48) CYP1B1CYP1A1CYP1A2GABRPGABRD
SCHEMBL24046903 0.73 GABRP (0.52) CYP1B1CYP1A1CYP1A2GABRPGABRD
SCHEMBL311288 0.70 LOXL2 (0.47) CYP1B1CYP1A1CYP1A2CCNT1CDK7
SCHEMBL24046989 0.66 TNKS (0.51) CYP1B1CYP1A1CYP1A2GABRPGABRD
SCHEMBL24046990 0.66 CSNK2A2 (0.50) CYP1B1CYP1A1CYP1A2GABRPGABRD
SCHEMBL312714 0.65 TNKS (0.62) CYP1B1CYP1A2GABRPGABRDGABRA1
SCHEMBL24046996 0.64 CYP1B1 (0.49) CYP1B1CYP1A1CYP1A2CSNK2A2CSNK2B
SCHEMBL311280 0.64 HPGD (0.61) CYP1B1CYP1A2ALDH1A1CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021236578-A1 CHROMEN-4-ONE DERIVATIVES, SUCH AS E.G. FLAVONES, FOR USE AS CK2 INHIBITORS FOR THE TREATMENT OF NEUROINFLAMMATION SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 2021-11-25 — — WO disclosed
Send feedback